Explore Investors, News, and more!

Explore related topics

Investors furious over Hanmi Pharmaceutical's report delay

Investors furious over Hanmi Pharmaceutical's report delay

How Analysts Feel About Craft Brew Alliance Inc  https://l.kchoptalk.com/2tZUTTM

How Analysts Feel About Craft Brew Alliance Inc (NASDAQ:BREW)?

Half Robert International Inc 2017 Institutional Investor Sentiment Worse Than Expected - Weekly Register

Dealpolitik: Pharma Investors Deserve Better Information - MoneyBeat - WSJ

Dealpolitik: Pharma Investors Deserve Better Information

Valeant Said to Be Planning to Raise Its Bid for Salix Pharmaceuticals

Carrières | Métro Montréal La poignée de main

Carrières | Métro Montréal La poignée de main

Investors in Female Viagra Are Slamming Valeant

Investors in Female Viagra Are Slamming Valeant

Investors in female Viagra maker, Sprout, are asking Valeant for proof that it's held up its side of the acquisition. And it could lead to litigation.

Are Investors Betting On Pfizer Inc. Coming Back For AstraZeneca plc? | The Motley Fool UK

It's hard to figure out why AstraZeneca plc (LON:AZN) rallied in the last few weeks of trading, argues this Fool.

Teva Is on the Prowl and Its Stock Investors Are Taking Notice

Teva Is on the Prowl and Its Stock Investors Are Taking Notice

Executives at Teva Pharmaceutical Industries Ltd., the world’s biggest generic drugmaker, keep dropping hints that they’re ready to make a large acquisition.

Deals of the Year 2014: Actavis Realizes Bigger Pharma Ambitions | Institutional Investor

8 Fascinating Facts About the Injectable That Changed the Beauty Industry

Shire CEO Looks Ahead To Independent Future SHPG ABBV - Investors.com

Shire CEO Looks Ahead To Independent Future

Flemming Ornskov has been at Shire for only 18 months, but his term has been quite an adventure already.

Can Actavis deliver a promised $6B boost from this pipeline? - FierceBiotech

New chief picks team to fuse Actavis with Allergan - FiercePharma

Should Investors Pay Attention to the Alleged Productivity Crises in Pharma?

Should Investors Pay Attention To The Alleged Productivity Crises In Pharma?

Investors, Pay Attention, Productivity, Health, News, Salud, Healthy, Health Care

GlaxoSmithKline should be split, star investor Woodford says - BBC News

Woodford calls for GSK break up

Drugs giant GlaxoSmithKline needs radical restructuring and should be broken up, says one of Britain's most successful investors, Neil Woodford.

One man's mission to open doors for investors

One man's mission to open doors for investors

Biotech investor Brad Loncar is on a mission to persuade every presenting company at an upcoming biotech conference to also webcast its breakout session.

Wait, It Costs How Much? Biotech Balances Optimism, Uncertainty For 2018

Wait, It Costs How Much? Biotech Balances Optimism, Uncertainty For 2018

Inventors, investors and fundraisers from the pharmaceutical industry arrived at the annual J. Morgan Healthcare Conference, their annual kickoff party, with lots of questions.

Lucas Jackson | Reuters. The ex-Turing Pharmaceuticals CEO is charged with looting a pharma company he founded to pay off hedge fund investors he was suspected of scamming.

Martin Shkreli taunts fed prosecutors after judge gives him exactly what he wants

Pharma bad boy Martin Shkreli unloaded as he left the federal courthouse in Brooklyn Monday.

A Word of Advice for Amgen: Objects in the Mirror Are Closer Than They Appear - The Motley Fool

A Word of Advice for Amgen: Objects in the Mirror Are Closer Than They Appear

This Is a Concern That Amgen Investors Shouldn't Take Lightly

Pinterest
Search